RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Olorunseun Ogunwobi to Pancreatic Neoplasms

This is a "connection" page, showing publications Olorunseun Ogunwobi has written about Pancreatic Neoplasms.
Connection Strength

0.996
  1. Harricharran T, Ogunwobi OO. Oxytocin and oxytocin receptor alterations, decreased survival, and increased chemoresistance in patients with pancreatic cancer. Hepatobiliary Pancreat Dis Int. 2020 Apr; 19(2):175-180.
    View in: PubMed
    Score: 0.626
  2. Agrawal R, Chen M, Bukhari Z, Ogunwobi OO, Haseeb MA, Martello LA. EZH2 Downregulation Augments the Effect of Irradiation in Reducing Pancreatic Cancer Cell Proliferation in vitro. Ann Clin Lab Sci. 2020 Jan; 50(1):45-56.
    View in: PubMed
    Score: 0.157
  3. George TJ, Ogunwobi OO, Sheng W, Fan ZH, Liu C. "Tissue is the issue": circulating tumor cells in pancreatic cancer. J Gastrointest Cancer. 2014 Dec; 45 Suppl 1:222-5.
    View in: PubMed
    Score: 0.110
  4. Sheng W, Ogunwobi OO, Chen T, Zhang J, George TJ, Liu C, Fan ZH. Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip. Lab Chip. 2014 Jan 07; 14(1):89-98.
    View in: PubMed
    Score: 0.103
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support